Monopar Therapeutics, Inc. (MNPR)
59.27
-1.72
(-2.82%)
USD |
NASDAQ |
May 15, 16:00
59.42
+0.15
(+0.25%)
After-Hours: 20:00
Monopar Therapeutics Shareholders Equity (Quarterly) : 135.39M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 133.90M |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
| Plus Therapeutics, Inc. | 11.96M |
| Perspective Therapeutics, Inc. | 347.44M |
| AVITA Medical, Inc. | -23.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 137.98M |
| Total Liabilities (Quarterly) | 2.589M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 56.05 |
| Net Debt Paydown Yield | -0.01% |